PPT-Tailoring Statin Therapy in Women

UnderRepresentation of Women in Clinical Trials CVD in Women Women s CV Risk is Often Misunderstood or Misdiagnosed Gender Disparities in Screening Diagnosis and Treatment of Dyslipidemia. Louis H. Stein, Jessica Berger, Maryann . Tranquilli. , . John A. . Elefteriades. .. . The Aortic Institute at Yale – New Haven Hospital . Bench top to bedside interaction. . Medial Degeneration . Liam O'Sullivan. Electronic . and Electrical Engineering, . Trinity College Dublin, Ireland. Trinity College Dublin. Tailoring Tabletop Interfaces for Musical Control. Proliferation of . multitouch. . Nice Guidelines . Who to offer therapy to?. Offer . lipid-modification . therapy. to. people aged 84 years and younger if their estimated 10-year risk of developing cardiovascular disease (CVD) using the . Yue Li. , . Tian. Tan, . Yifei. Zhang and Jingling . Xue. UNSW Australia. ECOOP 2016. Rome, Italy. 1. Program Slicing. Program slicing. [Weiser 1981] citation: 3950. 2. Program Slicing. Debugging. Maintenance. DO NOT BURN THE COOKIES. Amy R. Woods, M.D.. a. common goal. a. common goal. “These guidelines are meant to define practices that meet the needs of patients in most circumstances and are not a replacement for clinical judgment. The ultimate decision about care of a particular patient must be made by the healthcare provider and patient in light of the circumstances presented by that patient. As a result, situations might arise in which deviations from these guidelines may be appropriate. These considerations notwithstanding, in caring for most patients, clinicians can employ the recommendations confidently to reduce the risks of atherosclerotic cardiovascular disease (ASCVD) events.”. James J. Lehman, DC, MBA, FACO. Associate Professor of Clinical Sciences. School of Chiropractic. Director. Community Health Clinical Education. University of Bridgeport. Learning Objectives. . Organize a clinical thought process while performing a neuromusculoskeletal evaluation of a patient with statin myopathy and piriformis syndrome.. Control. Relative risk. Absolute Effect. (per thousand). Statin. Myalgia. 348/14960. (2.3%) . 288/14520. (2.0%). 1.02. (0.88-1.19). +1. (-1 to +5). Rhabdomyolysis. 138/2454. (5.6%). 158/2446. (6.5%). . Rabizadeh. , . MD. .. Imam . Khomeini . Medical . Complex,. Tehran . University of Medical Sciences. Introduction. Statin . use has . increased progressively in all age groups since . 1988 . The . /Lipid management in . Diabetes. Dr.Zahra. . davoudi. Endocrinology department of . Loghman. Hakim Hospital, . Shahid. . Beheshti. University of Medical Sciences. A . 65 year-old woman . with medical history of . Quality Department Guidelines for Clinical Care Ambulatory Lipid TherapyGuideline TeamTeam LeaderAudrey LFan, MDGeneral MedicineTeam MembersJill NFenske, MDFamily MedicineVan Harrison, PhDMedical Educ Alfred Fisher MD PhD. Professor and Chief. Division of Geriatrics, Gerontology,. and Palliative Medicine. University of Nebraska Medical Center. Older Patients in Primary Care often take Statins. Johansen, et. al. . of. Dyslipidemia. Navid Saadat, MD. Associate Professor of Endocrinology. Shahid Beheshti University of Medical Sciences. Rationale for . Treatment. Benefit . of . LDL-C. . reduction in . CVD events. Slide deck. The full text of the paper is available at. http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)31652-0/fulltext. . Rationale. Lipoprotein. (a) . is. an . established. . risk. Sex . Male. Diabetes. . History. T2D, . onset. @45 . yrs. , treatment: . metformin. , . sitagliptin. and . gliclazide. . Organ. . damage. . evaluation. :. Eyes. : No . signs. of . retinopathy.